CRISPR-based molecule-regulatory expression platform for specific immunotherapy of cancer
The constructed molecular sensors constructed specifically recognized the signal molecules within the cell and redirected the endogenous signal pathway to reprogram the fate of cancer cells.
Authors
- Tong Lu (ORCID: https://orcid.org/0009-0007-8022-1741)
- Tianying Zhan
- Jun Dong (ORCID: https://orcid.org/0000-0002-0026-6680)
- Linlin Wang (ORCID: https://orcid.org/0000-0001-9332-284X)
Institutions
- Third Affiliated Hospital of Guangzhou Medical University (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2024-10-23
- DOI
- https://doi.org/10.3389/fonc.2024.1469319
- Citations
- 1
- Primary Topic
- CRISPR and Genetic Engineering
- Type
- article
- Field-Weighted Citation Impact
- 0.23